Developments in Acute Lymphoblastic Leukemia Following ASH 2024 - Episode 7

Incorporating Blinatumomab into Clinical Practice for ALL

,

George Yaghmour, MD, and Rachel Elizabeth Rau, MD, discuss how to incorporate blinatumomab into clinical practice for ALL.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Frontline Treatment Considerations in Adult and Pediatric Acute Lymphoblastic Leukemia
    EP. 2: AlloHCT Outcomes From ECOG ACRIN E1910 in Newly Diagnosed, MRD-Negative B-Lineage ALL
    EP. 3: Adding Blinatumomab to Consolidation Therapy in Older Patients With Newly Diagnosed, BCR::ABL1–Negative B-ALL
    EP. 4: Approaching First-Line Treatment Decisions in Pediatric ALL
    EP. 5: Blinatumomab Plus Chemo in Newly Diagnosed, Standard-Risk Pediatric B-ALL
    EP. 6: Mitigation and Management Strategies for ICANS and Other AEs in ALL
    Now Viewing
    EP. 7: Incorporating Blinatumomab into Clinical Practice for ALL
    EP. 8: Ongoing Research to Watch in Acute Lymphoblastic Leukemia

    x